Keyphrases
Men Who Have Sex with Men
100%
HIV Pre-exposure Prophylaxis
35%
Sexually Transmitted Infections
35%
Pre-exposure Prophylaxis (PrEP)
33%
Sexual Health Clinic
31%
Shigella
28%
United Kingdom
27%
People Who Inject Drugs
25%
Shigella Flexneri
25%
Hepatitis C Virus
22%
Sexual Health Services
22%
Antimicrobial Resistance
21%
Risk Factors
20%
Shigella Species
20%
Behavioral Data
19%
Adult Male
18%
Clinical Outcomes
17%
Enteric Infections
17%
Reinfection
17%
Sexual Transmission
14%
Shigellosis
14%
Sexual Health
14%
Confidence Interval
13%
Unlinked
13%
Shigella Sonnei
12%
Seroprevalence
12%
Whole Genome Sequencing
11%
Whole-genome Sequence Data
11%
SNP
11%
Chlamydia Infection
10%
HIV Testing
10%
Seroprevalence Survey
10%
Chlamydia
10%
HIV-positive MSM
10%
Direct-acting Antivirals
10%
Clinical Data
10%
HIV-positive
10%
Surveillance Data
10%
Genetic Epidemiology
9%
Electronic Health Records
9%
Trichomonas Vaginalis Infection
8%
Genetic Diversity
8%
COVID-19 Pandemic Effects
8%
Persistent Carriage
8%
COVID-19 Pandemic Response
8%
T. Vaginalis
8%
Acquired Infections
8%
Gastrointestinal Infection
8%
Sexual Exposure
8%
Epidemiological Data
8%
Medicine and Dentistry
Men Who Have Sex with Men
90%
Human Immunodeficiency Virus
78%
Pre-Exposure Prophylaxis
26%
Shigella
25%
Health Service
21%
Prevalence
20%
Whole Genome Sequencing
20%
Infection
20%
Shigella flexneri
18%
Public Health
18%
Gene Linkage
18%
Cross Sectional Study
17%
Sexually Transmitted Infection
17%
Intestine Infection
17%
Single Nucleotide Polymorphism
14%
Pathogen
12%
Bacillary Dysentery
11%
Hepatitis Virus
10%
Chlamydiae
9%
Reinfection
9%
Mortality Rate
9%
COVID-19
9%
Hepatitis C
9%
Gastrointestinal Infection
8%
Chlamydia Infection
8%
Shigella sonnei
8%
Human T Cell Leukemia Virus
8%
Genetic Variability
8%
Seroprevalence
8%
Hepatitis C Virus
8%
Technology Assessment
8%
Health Technology
8%
Post-Exposure Prophylaxis
8%
Cohort Effect
8%
Pelvic Inflammatory Disease
8%
Case-Control Study
8%
Antiviral Drug
8%
Hepatocellular Carcinoma
8%
End Stage Liver Disease
8%
Hepatitis B Virus
8%
Hepatitis B
8%
Azithromycin
6%
Chlamydia Trachomatis
6%
Syphilis
5%
Human T-Lymphotropic Virus 1
5%
Enteroaggregative Escherichia Coli
5%
